MedPath

A study to compare the effectiveness of two drugs, Dexamethasone versus Methylprednisolone in the treatment of moderate Covid 19 patients

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/12/029894
Lead Sponsor
SRM Medical College Hospital and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Hospitalized patients with moderate SARS-COV-2 infection laboratory confirmed by RT-PCR

(Moderate COVID 19- SPO2 <94% Under room air and requiring supplemental oxygen for hypoxemia

Respiratory rate 24-30/min

NLR >5

CRP 50-100 mg/l

Serum ferritin 600-1500 ng/ml

Serum LDH 300-500 IU/l

D Dimer 0.5-1.0 mic/ml

IL-6 20-100 pg/ml

CT chest showing 25-75% infiltrates)

Exclusion Criteria

1.Patients with mild and severe covid pneumonia

2.Patients who are already on steroid treatment for any underlying condition

3.Patients already started on antivirals

4.Pregnant or lactating women

5.Any known contraindication to short term corticosteroid like severe immunosuppression, HIV infection or any other immunosuppressant usage

 

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mortality during hospital stayTimepoint: Day 1 - Day 7
Secondary Outcome Measures
NameTimeMethod
1.Time taken to wean off supplemental oxygen <br/ ><br>2.Need for mechanical ventilationTimepoint: Day 1 of enrollment in the study to Day 7
© Copyright 2025. All Rights Reserved by MedPath